Abbott's Q3: Met Expectations, Stock Dips. What's Next?
Update: 2025-10-16
Description
Abbott's Q3 Earnings: A Mixed Bag! Abbott met Wall Street's expectations with a 7% sales jump to $11.37 billion, driven by booming medical device sales. But, the stock dipped 4% on worries about slowing diagnostics in China and margin pressures. Despite the hiccup, Abbott is betting big on new products and global growth to hit high single-digit sales increases. Will their pipeline deliver, or will China and nutrition drag them down?
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
